Emiko Suzuki

1.6k citations
36 papers · 1.1k indexed · h-index 13

Emiko Suzuki

32 papers receiving 1.0k citations

Peers

Emiko Suzuki
Comparison fields: 5 of 125
  • Pharmaceutical Science 150
  • Complementary and alternative medicine 138
  • Health, Toxicology and Mutagenesis 169
  • Physiology 261
  • Endocrinology, Diabetes and Metabolism 165
Replace D. R. Krishna with:
D. R. Krishna India
Mikio Masada Japan
Mohamadi Sarkar United States
Pawan G. Nayak India
Joyce Trujillo Mexico
Robert Z. Harris United States
Zeng Fan-dian China
William D. Heizer United States
Saeed Alshahrani Saudi Arabia
Michel Audran France
Emiko Suzuki relative to D. R. Krishna India D. R. Krishna's profile →
Citations per field
00.5×2.8×
D. R. Krishna · 1×
Citations per year

Countries citing papers authored by Emiko Suzuki

Since Specialization
Citations

This map shows the geographic impact of Emiko Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiko Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiko Suzuki more than expected).

Fields of papers citing papers by Emiko Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emiko Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiko Suzuki. The network helps show where Emiko Suzuki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Emiko Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emiko Suzuki Line = papers co-authored together Emiko Suzuki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20231
3 201612
4 201559
5 20148
6 20131
7 20128
8 201113
9 20111
10 201012
11 20022
12 200110
13 20001
14 199921
15 19968
16 199231
17 19904
18 19891
19 19896
20 19885

About Emiko Suzuki

Emiko Suzuki is a scholar working on Pharmacology, Biochemistry and Applied Microbiology and Biotechnology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Phytochemicals and Antioxidant Activities (3 papers), Vitamin C and Antioxidants Research (3 papers), Biochemical Acid Research Studies (2 papers), Heavy Metal Exposure and Toxicity (2 papers), Tea Polyphenols and Effects (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Pharmaceutical Science (150 citations), Complementary and alternative medicine (138 citations) and Health, Toxicology and Mutagenesis (169 citations). Emiko Suzuki has collaborated with scholars based in Japan, Netherlands and United States. Frequent co-authors include Norio Shibata, Yoshio Takéuchi, Kazuo Kondo, Satoru Kodama, Hirohito Sone, Kazumi Saito, Yasuko Sone, Shiro Tanaka, Yasuo Ohashi and Nobuhiro Yamada. Their work appears in journals such as Journal of the American Chemical Society, The Science of The Total Environment and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026